Pivotal trial to investigate aldoxorubicin in combination with Avastin in patients with relapsed glioblastoma

Trial Profile

Pivotal trial to investigate aldoxorubicin in combination with Avastin in patients with relapsed glioblastoma

Planning
Phase of Trial: Phase III

Latest Information Update: 29 Jun 2015

At a glance

  • Drugs Aldoxorubicin (Primary) ; Bevacizumab (Primary)
  • Indications Glioblastoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Jun 2015 New trial record
    • 21 May 2015 According to a CytRx Corporation media release, the potential for this pivotal trial will be discussed at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top